Ekiti-born UNMC researcher, Akomolafe shines at U.S. Cancer Research Conference
An Ekiti-born scholar and doctoral student at the University of Nebraska Medical Center (UNMC), Ayomide Akomolafe has been commended for his oral presentation at the 2026 IDeA State Trainee Cancer
An Ekiti-born scholar and doctoral student at the University of Nebraska Medical Center (UNMC), Ayomide Akomolafe has been commended for his oral presentation at the 2026 IDeA State Trainee Cancer Research Conference held West Virginia University Cancer Institute Morgantown, West Virginia, United States.
Akomolafe, who hails from Ikere-Ekiti in Ekiti State, was among the 21 researchers selected for oral presentations at the conference after competitive abstract review process.
The three-day event, brought together trainees and experts in cancer research to present findings and exchange ideas.
Advertisement
300x250
Akomolafe’s presentation, titled "Blocking Histamine 1 Receptor Signaling Suppresses Gliobatoma Cell Proliferation and Progression” was delivered during one of the conference’s oral sessions.
Akomolafe’s current research builds on earlier findings in glioblastoma, a highly aggressive that accounts for approximately 50% of all primary brain tumor in the United States.
In his previous study, he examined the role of histamine signaling in GBM tumor proliferation and progression and reported that Dexbrompheniramine, an antihistamine, showed potential in inhibiting the growth of glioblastoma cells, including treatment-resistant variants.
The study indicated that the drug could selectively induce cancer cell death through multiple pathways with no toxicity to healthy brain cells, a development considered relevant in ongoing efforts to identify safer treatment options.
The work also aligns with research into drug repurposing, where existing medications are explored for new therapeutic uses.
Advertisement
300x250
At the conference, Akomolafe expanded on these findings, focusing on treatment response and underlying molecular mechanisms. His presentation drew engagement from participants during the question session.
The organisers noted that only a limited number of abstracts were selected for oral presentation, reflecting the standard of submissions received for this year’s conference.
Akomolafe’s participation adds to a growing list of Nigerian researchers contributing to international scientific discourse, particularly in the area of cancer research.
